TNF and type 1 diabetes mellitus: Monocytes from T1D patients show increased release of proinflammatory cytokines IL-6, IL-1β, and tumor necrosis factor α (TNFα) after ex vivo activation of monocytes by interferon γ (IFNγ) or lipopolysaccharide (LPS) [28, 29].